News | RIVM

Launch of the European project RISK-HUNT3R

The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.

Effects of COVID-19 vaccination becoming increasingly visible

In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.

At least 87% of people over 65 vaccinated at least once: high turnout, few regional differences

Four months after the launch of the vaccination campaign, at least 87% of people over 65 in the Netherlands have been vaccinated against COVID-19 at least once.

Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands

In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a study on the quality of SARS-CoV-2 antigen diagnostics in the Netherlands.

Long-term symptoms more common after Lyme disease

More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.

RIVM updates guidelines for AstraZeneca interval

As of 21 May, RIVM updated the guidelines for the interval between two doses of the AstraZeneca vaccine. The interval can now be between 6 and 14 weeks.

Social well-being is improving, compliance with coronavirus measures remains important

With the recent easing of the coronavirus measures, social contact and well-being are improving again. Compliance with most measures remains stable for now (such as getting tested by the GGD and avoiding crowds) or is decreasing very gradually.

Breast cancer screening resumes on Bonaire after COVID-19 hiatus

Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.

Downward trend remains steady

In the past calendar week, there were 32% fewer hospital admissions of patients with COVID-19 compared to the week before. New arrivals in the ICU were also down by 23% compared to the previous week.

RIVM launches study on Long COVID

This week RIVM launched the Long COVID study. RIVM is asking people in the Netherlands who test positive for COVID-19 to sign up for the study via LongCOVID.rivm.nl within 7 days after their positive test result.